Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPD

Chest

Volumn 142, Issue 2, 2012, Pages 347-357

  Zhu, Jie ^a   Bandi, Venkata ^b   Qiu, Shengyang ^a   Figueroa, David J ^c   Evans, Jilly F ^c   Barnes, Neil ^d   Guntupalli, Kay K ^b   Jeffery, Peter K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BEN TAUB GENERAL HOSPITAL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CYSTEINYL LEUKOTRIENE 1 RECEPTOR; LEUKOTRIENE RECEPTOR; MESSENGER RNA; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BRONCHITIS; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CD4+ T LYMPHOCYTE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MACROPHAGE; MALE; MAST CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOKING; VIRUS INFECTION;

EID: 84864795241     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1581     Document Type: Article

References (28)

1. Holgate ST, Peters-Golden M. Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthma. J Allergy Clin Immunol. 2003;111(suppl 1):S1-S4.
2. Krawiec ME, Wenzel SE. Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma. Expert Opin Pharmacother. 2001;2(1):47-65.
3. Drazen JM. Anti-leukotrienes as novel anti-inflammatory treatments in asthma. Adv Exp Med Biol. 2002;507:217-221.
4. Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol. 2004;114(1):73-79.
5. Jeffery PK. The roles of leukotrienes and the effects of leukotriene receptor antagonists in the inflammatory response and remodelling of allergic asthma. Clin Exp Allergy Rev. 2001;1(2):148-153.
6. Wenzel SE. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids. 2003;69(2-3):145-155.
7. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164(10 pt 2):S28-S38.
8. Qiu Y, Zhu J, Bandi V, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168(8):968-975.
9. Qiu Y, Zhu J, Bandi V, Guntupalli KK, Jeffery PK. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax. 2007;62(6):475-482.
10. Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1646-1652.
11. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med. 1997;156(3 Pt 1):737-743.
12. Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399(6738):789-793.
13. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000;275(39):30531-30536.
14. Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy. 2003;33(10):1380-1388.
15. Barnes PJ. Distribution of receptor targets in the lung. Proc Am Thorac Soc. 2004;1(4):345-351.
16. Singh RK, Gupta S, Dastidar S, Ray A. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology. 2010;85(6):336-349.
17. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med. 2001;163(1):226-233.
18. Shirasaki H, Kanaizumi E, Watanabe K, et al. Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy. 2002;32(7):1007-1012.
19. Zhu J, Qiu YS, Figueroa DJ, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol. 2005;33(6):531-540.
20. Zhu J, Qiu YS, Bandi V, et al. CysLT1 receptor gene and protein expression in bronchial biopsies of chronic obstructive pulmonary disease: increase in severe exacerbation [abstract]. Am J Respir Crit Care Med. 2007;17S:A570.
21. Zhu J, Bandi V, Qiu SY, et al. Inflammatory cells in bronchial biopsies of COPD: increase/decrease in severe exacerbations [abstract]. Am J Respir Crit Care Med. 2011;183:A2253.
22. D'silva L, Cook RJ, Allen CJ, Hargreave FE, Parameswaran K. Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med. 2007;101(10):2217-2220.
23. Riccioni G, Bucciarelli T, Mancini B, Di Ilio C, D'Orazio N. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem. 2007;14(18):1966-1977.
24. Austen KF. The mast cell and the cysteinyl leukotrienes. Novartis Found Symp. 2005;271:166-175.
25. Mortaz E, Redegeld FA, Sarir H, et al. Cigarette smoke stimulates the production of chemokines in mast cells. J Leukoc Biol. 2008;83(3):575-580.
26. Gosman MM, Postma DS, Vonk JM, et al. Association of mast cells with lung function in chronic obstructive pulmonary disease. Respir Res. 2008;9:64.
27. Andersson CK, Mori M, Bjermer L, Löfdahl CG, Erjefält JS. Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(3):206-217.
28. Ennis M. New targets for modifying mast cell activation in asthma. Curr Allergy Asthma Rep. 2006;6(3):247-251.